CLINICAL_TRIALS
trial_result
· 2009-10-02
Clinical Trial Update: Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH [Phase 3]
Summary
Phase 3 clinical trial update reporting long-term safety data for Alfuzosin (SL77.0499-10) in men with Benign Prostatic Hyperplasia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Benign Prostatic Hyperplasia | Phase 3 | Status: COMPLETED